Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Real business experts are wrong all the time, especially in pharmacy and healthcare. Isradipine is as much of a wild card as you can get... new indication on an old generic can be very lucrative.
.03 to .09 today. That’s a 300% swing since I know logic like math isn’t the strong suit here. Sorry to interrupt your broken 8 ball predictions.
So frustrating
Literally all of those things were present in one way or another over the past 3 years (including the agents of "fact", who cried the loudest doom and gloom before the biggest run of that time period.) Where was your prediction that ATTBF would be cleared and dismissed from the temporary order?
Hello AMRX! And Hello Shorty! Seems AMRX is undervalued but muddled by the Impax/Global buyout last year. Anyways, welcome to the board, let's see if we can get back to $20+ in 2019
WOW - Talk about cutting your nose to spite your face.
Looks like India is the right place and right time for a tech and manufacturing boom
https://ih.advfn.com/stock-market/NASDAQ/apple-AAPL/stock-news/79092672/foxconn-looks-to-india-and-beyond-china-for-ipho
For sure. It was a rough EOY but definitely love the buy opportunities created. Things are looking alright for old Valeant going into the new year. Glad I added at 18 to average down the $25 shares I was holding before.
Sounds like you were advising selling for a 90% loss and couldn’t even get that to go through. What a cocksucker.
From someone who was looking for immediate gratification years ago, I must say I’m very appreciative of the effort and leadership you’ve put into NXUR. Other longs were a great learning tool as well
Would you rather listen to people claiming to lose money on ATT or those saying it’s there you just have to eat enough of ihub’s shit to get it
I can assure you, I made no such assertion.
I’ll stick to official press releases. Not like any of you ever gave a shit about whether I make or lose money.
If ever there’s a delay in Teva’s production, isradapine becomes a single source generic
They were until the last update
If I had consulting offices in Switzerland, Hong King and Czech Republic, I probably would have done the same thing they did.
With oil and pharmacy down like it is, we are either in the midst of a major financial collapse (which I don’t believe) or investors are tired of CEOs cashing out 7 figure bonuses EOY while the people using the meds can’t even afford to buy them.
After seeing many of my stocks announce executive bonuses cashing out for 2018, it makes me chuckle when many of them are at 52 week lows... ATTBF holding, dipping, hoping that when the volume comes, the price goes up!!! Would love to ride free shares again until the next round of frustration comes along
Investigated by Amazon Echo maybe!! But give the OP a break, there’s not much difference between an investigation and regular pharmacy regulation hoop-jumping. Enjoy the weekend
Buying on the Christmas vacation rumor lol can’t resist below $20!!!
Stupid undervalued. Nobody has given the niche generic market the attention it deserves.
What an incredible title!! Good read. Nothing new about Abattis though. Same verbiage as the company PR at end of November.
More frustrators entering the arena as we speak. At least the original post had some personality to it.
Wow, thank you for going there! Dudes been a detriment to the company the whole time.
That’s life
Niche generic market is a nightmare for insurance and regulatory committees. Money is there, now we wait. In the meantime, see if you can find $ sales carbinoxamine tablets & liquid last year for an idea of how little pharmacy cares about the age of a product.
What do I mean by frustrating?
.042 to .075 in front of your face while emotions, message boards and computer models are saying strong sell... frustrating :-/
Frustrating
Frustrating
The .06 - .18 trade range doesn’t require this amount of attention or caution and doesn’t bring the investor drama as aggressively as it’s been lately. On the other hand, .03 - .74 involves more risk and greed hence the rise in FRUSTRATION whenever the goons arrive.
The .06 - .18 trade range doesn’t require this amount of attention or caution and doesn’t bring the investor drama as aggressively as it’s been lately. On the other hand, .03 - .74 involves more risk and greed hence the rise in FRUSTRATION whenever the goons arrive.
The .06 - .18 trade range doesn’t require this amount of attention or caution and doesn’t bring the investor drama as aggressively as it’s been lately. On the other hand, .03 - .74 involves more risk and greed hence the rise in FRUSTRATION whenever the goons arrive.
Probably more like $3mln after rebate and it’s another investment in vertical integration. Shady, yes... guilty, not sure.
Just like the rest of the economy. A crook is a crook, but even if conviction says bad egg involved, hopefully you bought a full dozen and move on with the rest. Doesn’t mean the case or carton is bad. I’m legitimately curious how it all shakes out, but shorty has been here since .11 so any market event that requires forced covering would be interesting to see. Problem with that is shorts probably have influence over board decisions. Would have to come from outside agent.
Thank you for keeping the board alive
Hang around. I can't overstate the importance of this stock's frustration level for at least 3 years now. The more frustrating it seems, the more likely its going to make a move...
PS The $22million paid for stock at 0.18 followed by $18million in rebate still comes out to about 70mln shares for $4mln or .057 a share. YOU HAVE SEEN THIS MODEL IN HEALTH INSURANCE. THE HEALTH CARE PROVIDER INVOICES/BILLS A CERTAIN AMOUNT BUT INSURANCE PAYS DISCOUNT OR REBATE FEE.
Actually, anybody care to explain how this is not a wholesale rebate model applied to investing? Buy X shares for Y dollars, receive Z in return as rebate after deal completes. Company receives Y-Z dollars from investor. Investor receives X shares at rebate price. Looks like pharmaceutical wholesale market in US...
Frustrating as ever!!! Guess it comes down to how much if any of that money actually made it to something that resembles business operations or assets and go from there. At the end of the day this shit grows from water, sunlight and common nutrients and minerals. Even beakers and buckets would be of value to a business entity willing to put in a little elbow grease.
Anybody have an NDC yet? Or Medispan lol